Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation

Med Mal Infect. 2019 Feb;49(1):69-71. doi: 10.1016/j.medmal.2018.10.011. Epub 2018 Nov 19.
No abstract available

Keywords: Amphotericin B; Amphotéricine B; Extracorporeal membrane oxygenation; Oxygénation par membrane extracorporelle; Pharmacocinétique; Pharmacokinetics.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacokinetics*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacokinetics*
  • Antifungal Agents / therapeutic use
  • Antigens, Fungal / analysis
  • Area Under Curve
  • Bronchoalveolar Lavage Fluid / immunology
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Galactose / analogs & derivatives
  • Humans
  • Invasive Pulmonary Aspergillosis / diagnosis*
  • Invasive Pulmonary Aspergillosis / diagnostic imaging
  • Invasive Pulmonary Aspergillosis / drug therapy
  • Liposomes
  • Mannans / immunology
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / metabolism*
  • Respiratory Distress Syndrome / therapy*

Substances

  • Antifungal Agents
  • Antigens, Fungal
  • Liposomes
  • Mannans
  • galactomannan
  • Amphotericin B
  • Galactose